The dual role model for p53 in maintaining genomic integrity

Cellular and Molecular Life Sciences

Volumn 55, Issue 1, 1999, Pages 12-27

  Janus, F ^a   Albrechtsen, N ^a   Dornreiter, I ^a   Wiesmuller L ^a   Grosse, F ^b   Deppert, W ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b FRITZ LIPMANN INSTITUTE   (Germany)

Author keywords

3' 5' exonuclease; DNA damage; DNA recombination; DNA repair; DNA replication; p53; Sequence specific DNA binding

Indexed keywords

DNA BINDING PROTEIN; PROTEIN P53;

BIOCHEMISTRY; DNA DAMAGE; DNA RECOMBINATION; DNA REPAIR; DNA REPLICATION; GENOME; GENOTOXICITY; HUMAN; MODEL; NONHUMAN; REVIEW; TRANSACTIVATION; TUMOR SUPPRESSOR GENE;

DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; EXODEOXYRIBONUCLEASE V; EXODEOXYRIBONUCLEASES; GENE EXPRESSION REGULATION; RECOMBINATION, GENETIC; SIMIAN VIRUS 40; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033028021     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050266     Document Type: Review

References (178)

1. 1 Culotta E. and Koshland D. E. Jr. (1993) p53 sweeps through cancer research. Science 262: 1958-1961
2. 2 Soussi T., Legros Y., Lubin R., Ory K. and Schlichtholz B. (1994) Multifactorial analysis of p53 alterations in human cancer: a review. Int. J. Cancer 57: 1-9
3. 3 Vogelstein B. and Kinzler K. W. (1992) p53 function and dysfunction. Cell 70: 523-526
4. 4 Kastan M. B., Onyekwere O., Sidransky D., Vogelstein B. and Craig R. W. (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51: 6304-6311
5. 5 Fritsche M., Haessler C. and Brandner G. (1993) Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 8: 307-318
6. 6 Nelson W. G. and Kastan M. B. (1994) DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 14: 1815-1823
7. 7 Lane D. P. (1992) Cancer: p53, guardian of the genome. Nature 358: 15-16
8. 8 Cox L. S. and Lane D. P. (1995) Tumour suppressors, kinases and clamps: how p53 regulates the cell cycle in response to DNA damage. Bioessays 17: 501-508
9. 9 Gottlieb T. M. and Oren M. (1996) p53 in growth control and neoplasia. Biochim. Biophys. Acta Rev. Cancer 1287: 77-102
10. 10 Ko L. J. and Prives C. (1996) p53: puzzle and paradigm. Genes Dev. 10: 1054-1072
11. 11 Levine A. J. (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323-331
12. 12 Hupp T. R. and Lane D. P. (1994) Allosteric activation of latent p53 letramers. Curr. Biol. 4: 865-875
13. 13 Hall P. A., Meek D. and Lane D. P. (1996) p53 integrating the complexity. J. Pathol. 180: 1-5
14. 14 Maltzman W. and Czyzyk L. (1984) UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol. 4: 1689-1694
15. 15 Graeber T. G., Peterson J. F., Tsai M., Monica K., Fornace A. J. J. and Giaccia A. J. (1994) Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol. 14: 6264-6277
16. 16 Linke S. P., Clarkin K. C., Di Leonardo A., Tsou A. and Wahl G. M. (1996) A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev. 10: 934-947
17. 17 Lu X. and Lane D. P. (1993) Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell 75: 765-778
18. 18 Siegel J., Fritsche M., Mai S., Brandner G. and Hess R. D. (1995) Enhanced p53 activity and accumulation in response to DNA damage upon DNA transfection. Oncogene 11: 1363-1370
19. 19 Kastan M. B. (1993) p53: a determinant of the cell cycle response to DNA damage. Adv. Exp. Med. Biol. 339: 291-293
20. 20 El-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M. et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825
21. 21 Zhang W., Guo-X. Y. D. and Deisseroth A. B. (1994) The requirement of the carboxyl terminus of p53 for DNA binding and transcriptional activation depends on the specific p53 binding DNA element. Oncogene 9: 2513-2521
22. 22 Meek D. W. (1994) Post-translational modification of p53. Cancer Biol. 5: 203-210
23. 23 Martinez J. D., Craven M. T., Joseloff E., Milezarek G. and Bowden G. T. (1997) Regulation of DNA binding and transactivation in p53 by nuclear localization and phosphorylation. Oncogene 14: 2511-2520
24. 24 Hupp T. R., Meek D. W., Midgley C. A. and Lane D. P. (1992) Regulation of the specific DNA binding function of p53. Cell 71: 875-886
25. 25 Wang Y. and Prives C. (1995) Increased and altered DNA binding of human p53 by S and G2/M but not G1 cydin-dependent kinases. Nature 376: 88-91
26. 26 Takenaka I., Morin F., Seizinger B. R. and Kley N. (1995) Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases. J. Biol. Chem. 270: 5405-5411
27. 27 Hecker D., Page G., Lohrum M., Weiland S. and Scheidtmann K. H. (1996) Complex regulation of the DNA-binding activity of p53 by phosphorylation: differential effects of individual phosphorylation sites on the interaction with different binding motifs. Oncogene 12: 953-961
28. 28 Siliciano J. D., Canman C. E., Taya Y., Sakaguchi K., Appella E. and Kastan M. B. (1997) DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev. 11: 3471-3481
29. 29 Shieh S. Y., Ikeda M., Taya Y. and Prives C. (1997) DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91: 325-334
30. 30 Lane D. P. and Hall P. A. (1997) MDM2 arbiter of p53's destruction. Trends Biochem. Sci. 22: 372-374
31. 31 Kastan M. B., Zhan Q., El-Deiry W. D., Carrier F., Jacks T., Walsh W. V. et al. (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71: 587-597
32. 32 Harper J. W., Adami G. R., Wei M., Keyomarsi K. and Elledge S. J. (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816
33. 33 Xiong Y., Hannon G. J., Zhang H., Casso D., Kobayashi R. and Beach D. (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704
34. 34 Dulic V., Kaufmann W. K., Wilson S. J., Tlsty T. D., Lees E., Harper J. W. et al. (1994) p53-dependent inhibition of cyclin-dependent kinase activities in human fibrobalsts during radiation-induced G1 arrest. Cell 76: 1013-1023
35. 35 Waga S., Hannon G. J., Beach D. and Stillman B. (1994) The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574-578
36. 36 Li R., Waga S., Hannon G. J., Beach D. and Stillman B. (1994) Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371: 534-537
37. 37 Melendy T. and Stillman B. (1991) Purification of DNA polymerase delta as an essential simian virus 40 DNA replication factor. J. Biol. Chem. 266: 1942-1949
38. 38 Umar A., Buermeyer A. B., Simon J. A., Thomas D. C., Clark A. B., Liskay R. M. et al. (1996) Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis. Cell 87: 65-73
39. 39 Wold M. S. and Kelly T. (1988) Purification and characterization of replication protein A, a cellular protein required for in vitro replication of simian virus 40 DNA. Proc. Natl. Acad. Sci. USA 85: 2523-2527
40. 40 Fairman M. P. and Stillman B. (1988) Cellular factors required for multiple stages of SV40 DNA replication in vitro. EMBO J. 7: 1211-1218
41. 41 Moore S. P., Erdile L., Kelly T. and Fishel R (1991) The human homologous pairing protein HPP-1 is specifically stimulated by the cognate single-stranded binding protein hRP-A. Proc. Nutl. Acad. Sci. USA 88: 9067-9071
42. 42 Coverley D., Kenny M. K., Munn M., Rupp W. D., Lane D. P. and Wood R. D. (1991) Requirement for the replication protein SSB in human DNA excision repair. Nature 349: 538-541
43. 43 Wobbe C. R., Weissbach L., Borowiec J. A., Dean F. B., Murakami Y., Bullock P. et al. (1987) Replication of simian virus 40 origin-containing DNA in vitro with purified proteins. Proc. Natl. Acad. Sci. USA 84: 1834-1838
44. 44 Wold M. S. (1997) Replication protein A: a heterotrimeric, single-stranded DNA-binding protein required for eukaryotic DNA metabolism. Annu. Rev. Biochem. 66: 61-92
45. 45 Tanaka K., Miura N., Satokata I., Miyamoto I., Yoshida M. C., Satoh Y. et al. (1990) Analysis of a human DNA excision repair gene involved in group A xeroderma pigmentosum and containing a zine-finger domain. Nature 348: 73-76
46. 46 Robins P., Jones C. J., Biggerstaff M., Lindahl T. and Wood R. D. (1991) Complementation of DNA repair in xeroderma pigmentosum group A cell extracts by a protein with affinity for damaged DNA. EMBO J. 10: 3913-3921
47. 47 O'Donovan A. and Wood R. D. (1993) Identical defects in DNA repair in xeroderma pigmentosum group G and rodent ERCC group 5. Nature 363: 186-188
48. 48 Scherly D., Nouspikel T., Corlet J., Ucla C., Bairoch A. and Clarkson S. G. (1993) Complementation of the DNA repair defect in xeroderma pigmentosum group G cells by a human cDNA related to yeast RAD2. Nature 363: 182-185
49. 49 O'Donovan A., Scherly D., Clarkson S. G. and Wood R. D. (1994) Isolation of active recombinant XPG protein, a human DNA repair endonuclease. J. Biol. Chem. 269: 15965-15968
50. 50 He Z., Henricksen L. A., Wold M. S. and Ingles C. J. (1995) RPA involvement in the damage-recognition and incision steps of nucleotide excision repair. Nature 374: 566-569
51. 51 Liu V. F. and Weaver D. T. (1993) The ionizing radiation-induced replication protein A phosphorylation response differs between ataxia telangiectasia and normal human cells. Mol. Cell. Biol. 13: 7222-7231
52. 52 Brush G. S., Morrow D. M., Hieter P. and Kelly T. J. (1996) The ATM homologue MEC1 is required for phosphorylation of replication protein A in yeast. Proc. Natl. Acad. Sci. USA 93: 15075-15080
53. 53 Carty M. P., Zernik-Kobak M., McGrath S. and Dixon K. (1994) UV light-induced DNA synthesis arrest in HeLa cells is associated with changes in phosphorylation of human single-stranded DNA-binding protein. EMBO J. 13: 2114-2123
54. 54 Abramova N. A., Russell J., Botehan M. and Li R. (1997) Interaction between replication protein A and p53 is disrupted after UV damage in a DNA repair-dependent manner. Proc. Natl. Acad. Sci. USA 94: 7186-7191
55. 55 Li Y., Jenkins C. W., Nichols M. A. and Xiong Y. (1994) Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitior p21. Oncogene 9: 2261-2268
56. 56 Poon R. Y. C., Jiang W., Toyoshima H. and Hunter T. (1996) Cyclin-dependent kinases are inactivated by a combination of p21 and Thr-14Tyr-15 phosphorylation after UV-induced DNA damage. J. Biol. Chem. 271: 13283-13291
57. 57 Adams P. D., Sellers W. R., Sharma S. K., Wu A. D., Nalin C. M. and Daelin W. G. J. (1996) Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol. Cell. Biol. 16: 6623-6633
58. 58 Guadagno T. M. and Newport J. W. (1996) Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity. Cell 84: 73-82
59. 59 Dulic V., Stein G. H., Far D. F. and S. I. R. (1998) Nuclear accumulation of p21 Cip1 at the onset of mitosis: a role at the G2/M-phase transition. Mol. Cell. Biol. 18: 546-557
60. 60 Brugarolas J., Chandrasekaran C., Gordon J. I., Beach D., Jacks T. and Hannon G. J. (1995) Radiation-induced cell cycle arrest compromised by p21. Nature 377: 552-557
61. 61 Levedakou E. N., Kaufmann W. K., Alcorta D. A., Galloway D. A. and Paules R. S. (1995) p2ICIP1 is not required for the early G2 checkpoint response to ionizing radiation. Cancer Res. 55: 2500-2502
62. 62 Paules R. S., Levedakou E. N., Wilson S. J., Innes C. L., Rhodes N., Tlsty T. D. et al. (1995) Defective G2 checkpoint function in cells from individuals with familial cancer syndromes. Cancer Res. 55: 1763-1773
63. 63 Agarwal M. L., Agarwal A., Taylor W. R. and Stark G. R. (1995) p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA 92: 8493-8497
64. 64 Aloni-Grinstein R., Schwartz D. and Rotter V. (1995) Accumulation of wild-type p53 protein upon gamma-irradiation induces a G2 arrest-dependent immunoglobulin kappa light chain gene expression. EMBO J. 14: 1392-1401
65. 65 Stewart N., Hicks G. G., Paraskevas F. and Movat M. (1995) Evidence to a second cell cycle block at G2/M by p53. Oncogene 10: 109-115
66. 66 Goi K., Takagi M., Iwata S., Delia D., Asada M., Donghi R. et al. (1997) DNA damage-associated dysregulation of the cell cycle and apoptosis control in cells with germ-line p53 mutation. Cancer Res. 57: 1895-1902
67. 67 Schwartz D., Almog N., Peled A., Goldfinger N. and Rotter V. (1997) Role of wild type p53 in the G2 phase: regulation of the gamma-irradiation-induced delay and DNA repair. Oncogene 15: 2597-2607
68. 68 Hermeking H., Lengauer C., Polyak K., He T.-C., Zhang L., Thiagalingam S. et al. (1997) 14-3-3δ is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1: 3-11
69. 69 Aitken A., Amess B., Howell S., Jones D., Martin H., Patel Y. et al. (1992) The role of specific isoforms of 14-3-3 protein in regulating protein kinase activity in the brain. Biochem. Soc. Trans. 20: 607-611
70. 70 Aitken A., Howell S., Jones D., Madrazo J., Martin H., Patel Y. et al. (1995) Post-translationally modified 14-3-3 isoforms and inhibition of protein kinase C. Mol. Cell. Biochem. 149-150: 41-49
71. 71 Wang W. and Shakes D. C. (1996) Molecular evolution of the 14-3-3 protein family. J. Mol. Evol. 43: 384-398
72. 72 Ford J. C., al-Khodairy F., Fotou E., Sheldrick K. S., Griffiths D. J. and Carr A. M. (1994) 14-3-3 protein homologs required for the DNA damage checkpoint in fission yeast. Science 265: 533-535
73. 73 Sanchez Y., Wong C., Thoma R. S., Riehman R., Wu Z., Piwnica-Worms H. et al. (1997) Conservation of the chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 277: 1497-1501
74. 74 Pines J. (1991) Cyclins: wheels within wheels. Cell Growth Differ. 2: 305-310
75. 75 Furnari B., Rhind N. and Russell P. (1997) Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase. Science 277: 1495-1497
76. 76 Peng C. Y., Graves P. R., Thoma R. S., Wu Z., Shaw A. S. and Piwnica-Worms H. (1997) Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277: 1501-1505
77. 77 Ford J. M. and Hanawalt P. C. (1995) Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. Proc. Natl. Acad. Sci. USA 92: 8876-8880
78. 78 Ford J. M. and Hanawalt P. C. (1997) Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts. J. Biol. Chem. 272: 28073-28080
79. 79 Wang X. W., Yen H., Schaeffer L., Roy R., Moncollin V., Egly J.-M. et al. (1995) p53 modulation of TFIIH-associated nucleotide excision repair activity. Nature Genet. 10: 188-195
80. 80 Mirzayans R., Enns L., Dietrich K., Barley R. D. C. and Paterson M. C. (1996) Faulty DNA polymerase delta/epsilon-mediated excision repair in response to gamma radiation or ultraviolet light in p53-deficient fibroblast strains from affected members of a cancer-prone family with Li-Fraumeni syndrome. Carcinogenesis 17: 691-698
81. 81 Smith M. L., Chen I.-T., Zhan Q., O'Connor P. M. and Fornace A. J. Jr. (1995) Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogcne 10: 1053-1059
82. 82 Eller M. S., Maeda T., Magnoni C., Atwal D. and Gilehrest B. A. (1997) Enhancement of DNA repair in human skin cells by thymidine dinucleotides: evidence for a p53-mediated mammalian SOS response. Proc. Natl. Acad. Sci. USA 94: 12627-12632
83. 83 Leveillard T., Andera L., Bissonnette N., Schaeffer L., Bracco L., Egly J. M. et al. (1996) Functional interactions between p53 and the TFIIH complex are affected by tumour-associated mutations. EMBO J. 15: 1615-1624
84. 84 Xiao H., Pearson A., Coulombe B., Truant R., Zhang S., Regier J. L. et al. (1994) Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol. Cell. Biol. 14: 7013-7024
85. 85 Lu H., Fisher R. P., Bailey P. and Levine A. J. (1997) The CDK7-cycH-p36 complex of transcription factor IIH phosphorylates p53, enhancing its sequence-specific DNA binding activity in vitro. Mol. Cell. Biol. 17: 5923-5934
86. 86 Fesquet D., Labbe J. C., Derancourt J., Capony J. P., Galas S., Girard F. et al. (1993) The MO15 gene encodes the catalytic subunit of a protein kinase that activates cdc2 and other cyclin-dependent kinases/CDKs) through phosphorylation of Thr161 and its homologues. EMBO J. 12:3111-3121
87. 87 Poon R. Y., Yamashita K., Adamczewski J. P., Hunt T. and Shuttleworth J. (1993) The cdc2-related protein p40MO15 is the catalytic subunit of protein kinase that can activate p33cdk2 and p34cdc2. EMBO J. 12: 3123-3132
88. 88 Solomon M. J., Harper J. W. and Shuttleworth J. (1993) CAK, the p34cdc2 activating kinase, contains a protein identical or closely related to p40MO15. EMBO J. 12: 3133-3142
89. 89 Adamczewski J. P., Rossignol M., Tassan J. P., Nigg E. A., Moncollin V. and Egly J. M. (1996) MATI, cdk7 and cyclin H form a kinase complex which is UV light-sensitive upon association with TFIIH. EMBO J. 15: 1877-1884
90. 90 Feaver W. J., Svejstrup J. Q., Henry N. L. and Kornberg R. D. (1994) Relationship of CDK-activating kinase and RNA polymerase II CTD kinase TFIIH/TFIIK. Cell 79: 1103-1109
91. 91 Roy R., Adamczewski J. P., Seroz T., Vermeulen W., Tassan J. P., Schaeffer L. et al. (1994) The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor. Cell 79: 1093-1101
92. 92 Shiekhattar R., Mermelstein F., Fisher R. P., Drapkin R., Dynlacht B., Wessling H. C. et al. (1995) Cdk-activaling kinase complex is a component of human transcription factor TFIIH. Nature 374: 283-287
93. 93 Troelstra C., Odijk H., Wit J. D., Westerveld A., Thompson L. H., Bootsma D. et al. (1990) Molecular cloning of the human DNA excision repair gene ERCC-6. Mol. Cell. Biol. 10: 5806-5813
94. 94 Steinmeyer K. and Deppert W. (1988) DNA binding properties of murine p53. Oncogene 3: 501-507
95. 95 Bakalkin G., Selivanova G., Yakovleva T., Kiseleva E., Kashuba E., Magnusson K. P. et al. (1995) p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domain. Nucleic Acids Res. 23: 362-369
96. 96 Lee S. M., Cavallo L. and Griffith J. (1997) Human p53 binds Holliday junctions strongly and facilitates their cleavage. J. Biol. Chem. 272: 7532-7539
97. 97 Lee S., Elenbaas B., Levine A. and Griffith J. (1995) p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 81: 1013-1020
98. 98 Reed M., Woelker B., Wang P., Wang Y., Anderson M. E. and Tegtmeyer P. (1995) The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation. Proc. Natl. Acad. Sci. USA 92: 9455-9459
99. 99 Jayaraman L. and Prives C. (1995) Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell 81: 1021-1029
100. 100 Mummenbrauer T., Janus F., Mueller B., Wiesmueller L., Deppert W. and Grosse F. (1996) p53 protein exhibits 3'-to-5' exonuclease activity. Cell 85: 1089-1099
101. 101 Reference deleted in proof.
102. 102 Haber J. E. (1997) A super twist on the initiation of meiotic recombination. Cell 89: 163-166
103. 103 Xu L., Weiner B. M. and Kleckner N. (1997) Meiotic cells monitor the status of the interhomolog recombination complex. Genes Dev. 11: 106-118
104. 104 Lutzker S. G. and Levine A. J. (1996) A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation. Nature Med. 2: 804-810
105. 105 Wiesmüller L., Cammenga J. and Deppert VV. (1996) In vivo assay of p53 function in homologous recombination between simian virus 40 chromosomes. J. Virol. 70: 737-744
106. 106 Mekeel K. L., Tang W., Kachnic L. A., Luo C. M., DeFrank J. S. and Powell S. N. (1997) Inactivation of p53 results in high rates of homologous recombination. Oncogene 14: 1847-1857
107. 107 Bertrand P., Rouillard D., Boulet A., Levalois C., Soussi T. and Lopez B. S. (1997) Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein. Oncogene 14: 1117-1122
108. 108 Honma M., Zhang L. S., Hayashi M., Takeshita K., Nakagawa Y., Tanaka N. et al. (1997) Illegitimate recombination leading to allelic loss and unbalanced translocation in p53-mutated human lymphoblastoid cells. Mol. Cell. Biol. 17: 4774-4781
109. 109 Jasin M., de Villiers J., Weber F. and Schaffner W. (1985) High frequency of homologous recombination in mammalian cells between endogenous and introduced SV40 genomes. Cell 43: 695-703
110. 110 Snapka R. M., Shin C.-G., Permana P. and Strayer J. (1991) Aphidicolin-induced topological and recombinational events in simian virus 40. Nucleic Acids Res. 19: 5065-5072
111. 111 Kawasaki I., Bae Y. S., Eki T., Kim Y. and Ikeda H. (1994) Homologous recombination of monkey α-satellite repeats in an in vitro simian virus 40 replication system: possible association of recombination with DNA replication. Mol. Cell. Biol. 14: 4173-4182
112. 112 Perry M. E., Commane M. and Stark G. R. (1992) Simian virus 40 large tumor antigen alone or two cooperating oncogenes convert REF52 cells to a state permissive for gene aplification. Proc. Natl. Acad. Sci. USA 89: 8112-8116
113. 113 Ishizaka Y., Chernov M. V., Burns C. M. and Stark G. R. (1995) p53-dependent growth arrest of REF52 cells containing newly amplified DNA. Proc. Natl. Acad. Sci. USA 92: 3224-3228
114. 114 Cheng R. Z., Shammas M. A., Li J. and Reis R. J. S. (1997) Expression of SV40 large T antigen stimulates reversion of a chromosomal gene duplication in human cells. Exp. Cell Res. 234: 300-312
115. 115 Xia S. J., Shammas M. A. and Shmookler Reis R. J. (1997) Elevated recombination in immortal human cells is mediated by HsRAD51 recombinase. Mol. Cell. Biol. 17: 7151-7158
116. 116 Havre P. A., Yuan J. L., Hedrick L., Cho K. R. and Glazer P. M. (1995) p53 inactivation by HPV 16 E6 results in increased mutagenesis in human cells. Cancer Res. 55: 4420-4424
117. 117 Feitelson M. A., Zhu M., Duan L. X. and London W. T. (1993) Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 8: 1109-1117
118. 118 Yang T. T., Namba H., Hara T., TakmuraN., Nagayama Y., Fukata S. et al. (1997) p53 induced by ionizing radiation mediates DNA end-jointing activity, but not apoptosis of thyroid cells. Oncogene 14: 1511-1519
119. 119 Gersten K. M. and Kemp C. J. (1997) Normal meiotic recombination in p53-deficient mice. Nature Genet. 17: 378-379
120. 120 Rotter V., Schwartz D., Almon E., Goldfinger N., Kapon A., Meshorer A. et al. (1993) Mice with reduced levels of p53 protein exhibit the testicular giant-cell degenerative syndrome. Proc. Natl. Acad. Sci. USA 90: 9075-9079
121. 121 Sjoeblom T. and Laehdetie J. (1996) Expression of p53 in normal and gamma-irradiated rat testis suggests a role for p53 in meiotic recombination and repair. Oncogene 12: 2499-2505
122. 122 Bogue M. A., Zhu C. M., Aguilar-Cordova E., Donehower L. A. and Roth D. B. (1996) p53 is required for both radiation-induced differentiation and rescue of V(D)J rearrangement in scid mouse thymocytes. Genes Dev. 10: 553-565
123. 123 Guidos C. J., Williams C. J., Grandal I., Knowles G., Huang M. T. F. and Danska J. S. (1996) V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev. 10: 2038-2054
124. 124 Nacht M., Strasser A., Chan Y. R., Harris A. W., Schlissel M., Bronson R. et al. (1996) Mutations in the p53 and SCID genes cooperate in tumorigenesis. Genes Dev. 10: 2055-2066
125. 125 Sung P. and Robberson D. L. (1995) DNA strand exchange mediated by a RAD51-ssDNA nucleoprotein filament with polarity opposite to that of RecA. Cell 82: 453-461
126. 126 Baumann P., Benson F. E. and West S. C. (1996) Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro. Cell 87: 757-766
127. 127 Gupta R. C., Bazemore L. R., Golub E. I. and Radding C. M. (1997) Activities of human recombination protein Rad51. Proc. Natl. Acad. Sci. USA 94: 463-468
128. 128 Stürzbecher H.-W., Donzelmann B., Henning W., Knippschild U. and Buchhop S. (1996) p53 is linked directly to homologous recombination processive RAD51/RecA protein interaction. EMBO J. 15: 1992-2002
129. 129 Shen Z. Y., Pardington-Purtymun P. E., Comeaux J. C., Moyzis R. K. and Chen D. J. (1996) Associations of UBE21 with RAD52, UBL1, p53 and RAD51 proteins in a yeast two-hybrid system. Genomics 37: 183-186
130. 130 Biard D. S., Saintigny Y., Maratrat M., Paris F., Martin M. and Angulo J. E. (1997) Enhanced expression of the Kin17 protein immediately after low doses of ionizing radiation. Radiat. Res. 147: 442-450
131. 131 Bishop D. K. (1994) RecA homologs Dmc1 and Rad51 interact to form multiple nuclear complexes prior to meiotic chromosome synapsis. Cell 79: 1081-1092
132. 132 Ashley T., Plug A. W., Xu J., Solari A. J., Reddy G., Golub E. I. et al. (1995) Dynamic changes in Rad51 distribution on chromatin during meiosis in male and female vertebrates. Chromosoma 104: 19-28
133. 133 Terasawa M. A., Shinobara A., Hotta Y., Ogawa H. and Ogawa T. (1995) Localization of RecA-like recombination proteins on chromosomes of lily at various stages. Genes Dev. 9: 925-934
134. 134 Lim D.-S. and Hasty P. (1996) A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a p53 mutation. Mol. Cell. Biol. 16: 7133-7143
135. 135 Tsuzuki T., Fujii Y., Sakumi K., Tominaga Y., Nakao K., Sekiguchi M. et al. (1996) Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc. Natl. Acad. Sci. USA 93: 6236-6240
136. 136 Scully R., Chen J., Plug A., Xiao Y., Weaver D., Feunteun J. et al. (1997) Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88: 265-275
137. 6 early embryonic lethality by p53 or p21 null mutation. Nature Genet. 16: 298-302
138. 138 Ludwig T., Chapman D. L., Papaioannou V. E. and Efstratiadis A. (1997) Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev. 11: 1226-1241
139. 139 Savitsky A., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L. et al. (1995) A single ataxia telangiectasia gene with a product similar to P1-3 kinase. Science 268: 1749-1753
140. 140 Carr A. M. (1996) Checkpoints take the next step. Science 271: 314-315
141. 141 Barlow C., Liyanage M., Moens P. B., Deng C. X., Ried T. and Wynshaw-Boris A. (1997) Partial rescue of the prophase I defects of Atm-deficient mice by p53 and p21 null alleles. Nature Genet. 17: 462-466
142. 142 Dudenhöffer C., Rohaly G., Will K., Deppert W. and Wiesmüller L. (1998) Specific mismatch recognition in heteroduplex intermediates by p53 suggests a role in fidelity control of homologous recombination. Mol. Cell. Biol. 18: 5332-5342
143. 143 Alani E., Lee S., Kane M. F., Griffith J. and Kolodner R. D. (1997) Saccharomyces cerevisiae MSH2, a mispaired base recognition protein, also recognizes Holliday junctions in DNA. J. Mol. Biol. 265
144. 144 De Wind N., Dekker M., Berns A., Radman M. and Riele H. T. (1995) Inactivation of the mouse msh2 gene results in mismatch repair deficiency, methylation tolerance, hyper-recombination and predisposition to cancer. Cell 82: 321-330
145. 145 Baker S. M., Bronner C. E., Zhang L., Plug A. W., Robatzek M., Warren G. et al. (1995) Male mice defective in the mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell 82: 309-319
146. 146 Baker S. M., Plug A. W., Prolla T. A., Bronner C. E., Harris A. C., Yao X. et al. (1996) Involvement of mouse Mlhl in DNA mismatch repair and meiotic crossing over. Nature Genet. 13: 336-342
147. 147 Edelmann W., Cohen P. E., Kane M., Lau K., Morrow B., Bennett S. et al. (1996) Meiotic pachytene arrest in MLH1-deficient mice. Cell 85: 1125-1134
148. 148 Cranston A., Bocker T., Reitmair A., Palazzo J., Wilson T., Mak T. et al. (1997) Female embryonic lethality in mice nullizygous for both Msh2 and p53. Nature Genet. 17: 114-118
149. 149 Hughes M. J. and Jirieny J. (1992) The purification of a human mismatch-binding protein and identification of its associated ATPase and helicase activities. J. Biol. Chem. 267: 23876-23882
150. 150 Jessberger R., Podust V., Hübscher U. and Berg P. (1993) A mammalian protein complex that repairs double-strand breaks and deletions by recombination. J. Biol. Chem. 268: 15070-15079
151. 151 Deng C., Zhang P., Harper J. W., Elledge S. J. and Leder P. (1995) Mice lacking p21 cip1/waf1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684
152. 152 Hupp T. R., Sparks A. and Lane D. P. (1995) Small peptides activate the latent sequence-specific DNA binding function of p53. Cell 83: 237-245
153. 153 Modrich P. (1987) DNA mismatch correction. Annu. Rev. Biochem. 56: 435-466
154. 154 Modrich P. (1989) Methyl-directed DNA mismatch correction. J. Biol. Chem. 264: 6597-6600
155. 155 Bodmer W., Bishop T. and Karran P. (1994) Genetic steps in colorectal cancer. Nature Genet. 6: 217-219
156. 156 Modrich P. (1994) Mismatch repair, genetic stability and cancer. Science 266: 1959-1960
157. 157 Radman M. and Wagner R. (1993) Carcinogenesis. Missing mismatch repair. Nature 366: 722
158. 158 Bhattacharyya N. P., Skandalis A., Ganesh A., Groden J. and Meuth M. (1994) Mutator phenotypes in human colorectal carcinoma cell lines. Proc. Natl. Acad. Sci. USA 91: 6319-6323
159. 159 Leach F. S., Nicolaides N. C., Papadopoulos N., Liu B., Jen J., Parsons R. et al. (1993) Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75: 1215-1225
160. 160 Parsons R., Li G. M., Longley M. J., Fang W. H., Papadopoulos N., Jen J. et al. (1993) Hypermutability and mismatch repair deficiency in RER + tumor cells. Cell 75: 1227-1236
161. 161 Harvey M., McArthur M. J., Montgomery C. A. Jr., Butel J. S., Bradley A. and Donehower L. A. (1993) Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nature Genet. 5: 225-229
162. 162 Cottu P. H., Muzeau F., Estreicher A., Flejou J. F., Iggo R., Thomas G. et al. (1996) Inverse correlation between RER + status and p53 mutation in colorectal cancer cell lines. Oncogene 13: 2727-2730
163. 163 Fishel R. and Kolodner R. D. (1995) Identification of mismatch repair genes and their role in the development of cancer. Curr. Opin. Genet. Dev. 5: 382-395
164. 164 Kunkel T. A. (1992) DNA replication fidelity. J. Biol. Chem. 267: 18251-18254
165. 165 Kunkel T. A. (1986) Frameshift mutagenesis by eucaryotic DNA polymerases in vitro. J. Biol. Chem. 261: 13581-13587
166. 165a Huang P. (1998) Excision of mismatched nucleotides from DNA: a potential mechanism for enhancing DNA replication fidelity by the wild-type p53 protein. Oncogene 17: 261-270
167. 166 Deppert W. and Schirmbeck R. (1995) The nuclear matrix and virus function. Int. Rev. Cytol. 162A: 486-537
168. 167 Deppert W. and Haug M. (1986) Evidence for free and metabolically stable p53 protein in nuclear subfractions of simian virus 40-transformeti cells. Mol. Cell. Biol. 6: 2233-2240
169. 168 Suwa A., Hirakata M., Takeda Y., Jesch S. A., Mimori T. and Hardin J. A. (1994) DNA-dependent protein kinase (Ku protein-p350 complex) assembles on double-stranded DNA. Proc. Natl. Acad. Sci. USA 91: 6904-6908
170. 169 Tuteja N., Tuteja R., Ochem A., Taneja P., Huang N. W., Simonesits A. et al. (1994) Human DNA helicase II: a novel DNA unwinding enzyme identified as the Ku autoantigen. EMBO J. 13: 4991-5001
171. 170 WangT. S. (1991) Eukaryotic DNA polymerases. Annu. Rev. Biochem. 60: 513-552
172. 171 Saxena J. K., Hays J. B. and Ackerman E. J. (1990) Excision repair of UV-damaged plasmid DNA in Xenopus oocytes is mediated by DNA polymerase alpha (and/or delta). Nucleic Acids Res. 18: 7425-7432
173. 172 Oda N., Saxena J. K., Jenkins T. M., Prasad R., Wilson S. H. and Ackerman E. J. (1996) DNA polymerases alpha and beta are required for DNA repair in an efficient nuclear extract from Xenopus oocytes. J. Biol. Chem. 271: 13816-13820
174. 173 Wood R. D. and Shivji M. K. (1997) Which DNA poly0 merases are used for DNA-repair in eukaryotes? Carcinogenesis 18: 605-610
175. 174 Flores-Rozas H., Kelman Z., Dean F. B., Pan Z. Q., Harper J. W., Elledge S. J. et al (1994) Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme. Proc. Natl. Acad. Sci. USA 91: 8655-8569
176. 174a Kühn C., Müller F., Melle C., Nasheuer H.-P., Janus F., Deppert W. and Grosse F. (1999) Surface plasmon resonance measurements reveal stable complex formation between p53 and DNA ploymerase α. Oncogene, in press
177. 175 Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J. C., Valent A. et al. (1997) Monoallelically expressed gene related to p53 at [p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90: 809-819
178. 176 Schmale H. and Bamberger C. (1997) A novel protein with strong homology to the tumor suppressor p53. Oncogene 15: 1363-1367